Cardiovascular Burden of COVID-19 and the Post-Covid Era
| Autor: | Jefferson L. Vieira, Peter Libby, Samuel D. Moscavitch |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
medicine.medical_specialty
Fatal outcome Myocarditis Coronavirus disease 2019 (COVID-19) biology Hospitalized patients business.industry Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Severe disease Disease medicine.disease Troponin Internal medicine medicine Cardiology biology.protein business |
| Zdroj: | ABC: Heart Failure & Cardiomyopathy. 1:1-10 |
| ISSN: | 2764-3107 |
| Popis: | Why COVID-19 became an issue for cardiovascular specialists? SARS-CoV-2- related myocardial injury and myocarditis Approximately 20-30% of hospitalized patients with COVID-19 have evidence of cardiac injury, as indicated by elevated levels of high-sensitivity troponins. The presence and magnitude of troponin elevation is associated with more severe disease and worse outcomes, even after adjusting for relevant risk factors. Myocardial injury portends a fatal outcome of COVID-19, while the prognosis of patients without myocardial injury, even with underlying cardiovascular disease, is more [...] |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|